APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

Healthcare Services

Sharesguru Stock Score

APOLLOHOSP

45/100

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years

₹7348.00-25.00(-0.34%)

Market Closed as of Apr 7, 2026, 15:28 IST

Select time range

Pros

Smart Money: Smart money has been increasing their position in the stock.

Balance Sheet: Strong Balance Sheet.

Past Returns: Outperforming stock! In past three years, the stock has provided 20% return compared to 9.3% by NIFTY 50.

Growth: Good revenue growth. With 53% growth over past three years, the company is going strong.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Size: It is among the top 200 market size companies of india.

Profitability: Recent profitability of 8% is a good sign.

Cons

Momentum: Stock is suffering a negative price momentum. Stock is down -5.2% in last 30 days.

Valuation
Market Cap	1.05 LCr
Price/Earnings (Trailing)	58.38
Price/Sales (Trailing)	4.31
EV/EBITDA	29.6
Price/Free Cashflow	266.05
MarketCap/EBT	43.66
Enterprise Value	1.1 LCr

Fundamentals
Revenue (TTM)	24.42 kCr
Rev. Growth (Yr)	16.8%
Earnings (TTM)	1.87 kCr
Earnings Growth (Yr)	36.1%

Profitability
Operating Margin	10%
EBT Margin	10%
Return on Equity	19.53%
Return on Assets	8.5%
Free Cashflow Yield	0.38%

Growth & Returns
Price Change 1W	-3.5%
Price Change 1M	-5.2%
Price Change 6M	-1.8%
Price Change 1Y	8.7%
3Y Cumulative Return	20%
5Y Cumulative Return	20.4%
7Y Cumulative Return	28.6%
10Y Cumulative Return	18.4%

Cash Flow & Liquidity
Cash Flow from Investing (TTM)	-3.38 kCr
Cash Flow from Operations (TTM)	2.14 kCr
Cash Flow from Financing (TTM)	1.32 kCr
Cash & Equivalents	488.4 Cr
Free Cash Flow (TTM)	423.7 Cr
Free Cash Flow/Share (TTM)	29.47

Balance Sheet
Total Assets	21.95 kCr
Total Liabilities	12.4 kCr
Shareholder Equity	9.55 kCr
Current Assets	8.02 kCr
Current Liabilities	4.76 kCr
Net PPE	9.96 kCr
Inventory	505.4 Cr
Goodwill	1.03 kCr

Capital Structure & Leverage
Debt Ratio	0.24
Debt/Equity	0.56
Interest Coverage	4.41
Interest/Cashflow Ops	5.74

Dividend & Shareholder Returns
Dividend/Share (TTM)	20
Dividend Yield	0.27%
Shares Dilution (1Y)	0.00%
Shares Dilution (3Y)	0.00%

Technical Indicators
RSI (14d)	35.02
RSI (5d)	61.88
RSI (21d)	37.42
MACD Signal	Sell
Stochastic Oscillator Signal	Hold
SharesGuru Signal	Sell
RSI Signal	Hold
RSI5 Signal	Hold
RSI21 Signal	Hold
SMA 5 Signal	Sell
SMA 10 Signal	Sell
SMA 20 Signal	Sell
SMA 50 Signal	Sell
SMA 100 Signal	Sell

Description	Share	Value
a) Healthcare services	49.5%	3.2 kCr
c) Digital health and pharmacy distribution	43.4%	2.8 kCr
b) Retail health and diagnostics	7.2%	466.8 Cr
Total		6.5 kCr

Shareholder Name	Holding %
M/s. PCR Investments Ltd	18.93%
GOVERNMENT OF SINGAPORE	2.34%
MIRAE ASSET ELSS TAX SAVER FUND	2.13%
Ms. Suneeta Reddy	2.04%
AXIS MUTUAL FUND TRUSTEE LIMITED	1.82%
Ms. Sangita Reddy	1.69%
Ms. Shobana Kamineni	1.56%
SBI NIFTY 50 ETF	1.55%
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED	1.45%
NIPPON LIFE INDIA TRUSTEE LTD	1.32%
INVESCO INDIA CONTRA FUND	1.2%
FRANKLIN INDIA FLEXI CAP FUND	1.14%
Mr. K Vishweshwar Reddy	1.1%
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND	1.01%
Ms. Preetha Reddy	0.73%
Ms. Sindoori Reddy	0.22%
Ms. Anuspala Kamineni	0.18%
Dr. Prathap C Reddy	0.17%
Mr. Vijay Kumar Reddy	0.16%
Mr. Konda Anindith Reddy	0.16%

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
MAXHEALTH	Max Healthcare Institute	91.89 kCr	8.3 kCr	-11.90%	-13.70%	64.7	11.07	-	-
FORTIS	Fortis Healthcare	59.55 kCr	8.84 kCr	-15.70%	+19.00%	62.01	6.74	-	-
NH	Narayana Hrudayalaya	33.21 kCr	6.88 kCr	-12.30%	-3.70%	42.37	4.83	-	-
MEDANTA	Global Health	26.89 kCr	4.27 kCr	-15.60%	-19.80%	52.32	6.3	-	-
KIMS	Krishna Institute of Medical Sciences	25.05 kCr	3.65 kCr	-16.60%	+2.70%	83.49	6.87	-	-
LALPATHLAB	Dr. Lal Pathlabs	22.27 kCr	2.77 kCr	-6.30%	+6.40%	41.97	8.05	-	-
METROPOLIS	Metropolis Healthcare	2.19 kCr	1.59 kCr	-8.80%	+8.80%	12.99	1.38	-	-

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	14.4%	21,794	19,059	16,612	14,663	10,560	11,247
Other Income	89.5%	200	106	90	78	45	27
Total Income	14.8%	21,994	19,166	16,703	14,741	10,605	11,274
Cost of Materials	12.2%	2,754	2,454	2,284	2,685	1,623	1,809
Purchases of stock-in-trade	15.9%	8,557	7,385	6,315	4,961	4,186	3,797
Employee Expense	11%	2,769	2,494	2,144	1,787	1,601	1,853
Finance costs	2%	458	449	381	379	449	533
Depreciation and Amortization	10.3%	758	687	615	601	573	620
Other expenses	7.4%	4,693	4,369	3,845	3,118	2,137	2,308
Total Expenses	12.3%	19,988	17,805	15,559	13,457	10,445	10,812
Profit Before exceptional items and Tax	47.4%	2,006	1,361	1,144	1,284	160	462
Exceptional items before tax	-211.1%	0	1.9	0	294	61	198
Total profit before tax	47.3%	2,006	1,362	1,144	1,578	221	660
Current tax	20.4%	526	437	406	238	76	214
Deferred tax	-13%	7.7	8.7	-149.67	239	8.92	11
Total tax	19.8%	534	446	256	477	85	225
Total profit (loss) for period	61%	1,505	935	845	1,108	137	432
Other comp. income net of taxes	36%	-6.3	-10.4	-13.27	-9.72	15	-0.6
Total Comprehensive Income	62.1%	1,499	925	831	1,099	152	431
Earnings Per Share, Basic	61.9%	100.56	62.5	56.97	73.42	10.74	32.7
Earnings Per Share, Diluted	61.9%	100.56	62.5	56.97	73.42	10.74	32.7

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	2.7%	6,477	6,304	5,842	5,592	5,527	5,589
Other Income	-3.7%	53	55	40	61	64	38
Total Income	2.7%	6,530	6,358	5,882	5,653	5,591	5,628
Cost of Materials	-4.4%	745	779	740	694	626	744
Purchases of stock-in-trade	8%	2,663	2,465	2,316	2,244	2,292	2,110
Employee Expense	-2.3%	749	767	713	725	686	700
Finance costs	2.8%	113	110	108	115	110	118
Depreciation and Amortization	0.5%	219	218	215	211	185	184
Other expenses	2.1%	1,381	1,352	1,230	1,169	1,178	1,216
Total Expenses	2.7%	5,844	5,690	5,313	5,148	5,060	5,076
Profit Before exceptional items and Tax	2.7%	686	668	569	505	531	552
Exceptional items before tax	-	-19.2	0	0	0	0	0
Total profit before tax	-0.1%	667	668	569	505	531	552
Current tax	-9.3%	147	162	125	119	134	160
Deferred tax	0%	19	19	17	-18	22	1.9
Total tax	-8.3%	166	181	142	101	157	162
Total profit (loss) for period	4.5%	516	494	441	414	379	396
Other comp. income net of taxes	-102.1%	-0.2	57	5.9	-3	-2.9	-5.5
Total Comprehensive Income	-6.4%	516	551	447	412	376	390
Earnings Per Share, Basic	5.4%	34.94	33.19	30.1	27.1	25.89	26.34
Earnings Per Share, Diluted	5.4%	34.94	33.19	30.1	27.1	25.89	26.34

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Revenue From Operations	12.8%	8,202	7,274	6,525	6,098	9,153	9,794
Other Income	93.9%	348	180	152	47	18	11
Total Income	14.7%	8,550	7,454	6,676	6,145	9,171	9,805
Cost of Materials	12.5%	2,248	1,999	1,861	1,929	1,330	1,532
Purchases of stock-in-trade	-	0	0	0	0	4,155	3,754
Employee Expense	12.1%	1,597	1,425	1,239	1,150	1,275	1,519
Finance costs	1.6%	254	250	239	244	344	426
Depreciation and Amortization	12.6%	449	399	367	363	436	482
Other expenses	12.7%	2,313	2,052	1,743	1,599	1,573	1,678
Total Expenses	12%	6,861	6,125	5,449	5,286	8,985	9,287
Profit Before exceptional items and Tax	27%	1,688	1,329	1,228	859	186	518
Exceptional items before tax	-	0	0	0	-6.74	-9.09	164
Total profit before tax	27%	1,688	1,329	1,228	852	177	682
Current tax	26.2%	406	322	302	40	62	205
Deferred tax	-217.8%	-13.3	-3.5	-159.77	239	9.48	6.94
Total tax	23.3%	392	318	143	280	72	212
Total profit (loss) for period	28.3%	1,296	1,010	1,085	665	105	470
Other comp. income net of taxes	91.6%	0.2	-8.5	-11.14	-2.24	-5.58	0.75
Total Comprehensive Income	29.4%	1,296	1,002	1,074	663	100	471
Earnings Per Share, Basic	28.7%	90.15	70.28	75.45	46.26	7.51	33.8
Earnings Per Share, Diluted	28.7%	90.15	70.28	75.45	46.26	7.51	33.8
Debt equity ratio	-	-	-	025	-	082	082
Debt service coverage ratio	-	-	-	0.0231	-	0.0292	0.0292
Interest service coverage ratio	-	-	-	0.0713	-	0.0427	0.0427

Category	APOLLOHOSP	Healthcare
PE	58.38	56.90
PS	4.31	5.78
Growth	14.6 %	12.9 %

Description	(%) Q/Q	Dec-2025	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Revenue From Operations	0.3%	2,364	2,356	2,168	2,075	2,055	2,135
Other Income	-23.6%	108	141	32	92	108	121
Total Income	-1%	2,472	2,497	2,200	2,167	2,163	2,256
Cost of Materials	0.2%	612	611	590	562	569	581
Employee Expense	-4.9%	410	431	404	410	394	412
Finance costs	7%	62	58	59	63	62	65
Depreciation and Amortization	4.1%	127	122	123	130	108	108
Other expenses	3.8%	748	721	628	582	580	602
Total Expenses	0.8%	1,959	1,944	1,804	1,747	1,713	1,769
Profit Before exceptional items and Tax	-7.4%	513	554	397	420	449	488
Exceptional items before tax	-	-11.4	0	0	0	0	0
Total profit before tax	-9.4%	502	554	397	420	449	488
Current tax	-13.1%	107	123	89	99	105	120
Deferred tax	10%	12	11	0.4	-12.6	2.6	-2.2
Total tax	-12%	118	134	90	87	108	118
Total profit (loss) for period	-8.6%	384	420	307	333	342	370
Other comp. income net of taxes	62.6%	-2.4	-8.1	5.7	0.1	-2.5	-2.4
Total Comprehensive Income	-7.5%	381	412	313	334	339	367
Earnings Per Share, Basic	-9%	26.67	29.2	21.35	23.18	23.76	25.71
Earnings Per Share, Diluted	-9%	26.67	29.2	21.35	23.18	23.76	25.71
Debt equity ratio	-	-	-	-	-	-	-
Debt service coverage ratio	-	-	-	-	-	-	-
Interest service coverage ratio	-	-	-	-	-	-	-

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	-15.6%	488	578	1,435	506	472	433
Current investments	31.2%	1,878	1,432	698	684	562	292
Loans, current	-58.5%	2.7	5.1	3	4.9	5.67	5.63
Total current financial assets	16.1%	6,963	5,996	6,514	4,304	4,117	3,602
Inventories	5%	505	481	448	460	423	390
Current tax assets	-	208	0	-	-	252	-
Total current assets	14.1%	8,023	7,029	7,338	5,280	5,140	4,337
Property, plant and equipment	1.5%	9,965	9,816	9,043	8,540	7,771	7,432
Capital work-in-progress	33.1%	1,026	771	1,042	845	727	602
Investment property	-16.7%	2.5	2.8	3.1	3.4	3.75	4.06
Goodwill	0.2%	1,032	1,030	1,012	1,012	1,011	986
Non-current investments	8.7%	902	830	314	104	290	96
Loans, non-current	38.5%	37	27	31	6.6	6.9	8.37
Total non-current financial assets	11.5%	1,193	1,070	629	363	614	401
Total non-current assets	2.2%	13,927	13,628	12,210	11,473	10,421	10,091
Total assets	6.3%	21,950	20,657	19,548	16,753	15,561	14,428
Borrowings, non-current	1.5%	4,483	4,417	3,819	2,236	2,016	1,938
Total non-current financial liabilities	2.2%	7,011	6,862	6,081	4,227	4,409	4,052
Provisions, non-current	17%	104	89	81	73	56	57
Total non-current liabilities	2.8%	7,633	7,426	6,632	4,768	4,904	4,572
Borrowings, current	0%	858	858	1,029	926	994	773
Total current financial liabilities	3.4%	4,275	4,134	4,568	4,283	3,342	2,972
Provisions, current	9%	195	179	166	143	174	113
Current tax liabilities	183.3%	2.7	1.6	0.8	1.3	4.05	2.8
Total current liabilities	4%	4,764	4,579	5,001	4,664	3,780	3,325
Total liabilities	3.3%	12,397	12,004	11,633	9,433	8,683	7,896
Equity share capital	0%	72	72	72	72	72	72
Non controlling interest	4.3%	460	441	414	385	369	334
Total equity	10.4%	9,553	8,653	7,915	7,320	6,878	6,531
Total equity and liabilities	6.3%	21,950	20,657	19,548	16,753	15,561	14,428

Description	(%) Q/Q	Sep-2025	Mar-2025	Sep-2024	Mar-2024	Sep-2023	Mar-2023
Cash and cash equivalents	-33.2%	156	233	325	276	254	217
Current investments	31.2%	1,878	1,432	697	684	562	292
Loans, current	-42.9%	13	22	113	79	80	80
Total current financial assets	16.7%	3,669	3,143	3,054	3,280	3,186	2,820
Inventories	4.8%	133	127	127	119	112	98
Current tax assets	-	22	0	-	-	63	-
Total current assets	14.6%	4,032	3,518	3,372	3,675	3,506	3,151
Property, plant and equipment	1%	6,299	6,239	5,953	5,971	5,355	5,049
Capital work-in-progress	32.8%	390	294	295	172	97	89
Goodwill	-	0	0	0	0	0	0
Non-current investments	1.9%	2,525	2,479	2,467	1,938	1,938	1,925
Loans, non-current	25.7%	539	429	360	245	225	236
Total non-current financial assets	4.9%	3,212	3,061	2,985	2,361	2,400	2,292
Total non-current assets	2.9%	10,135	9,854	9,478	8,730	7,994	7,630
Total assets	5.9%	14,167	13,372	12,850	12,405	11,500	10,780
Borrowings, non-current	2.1%	1,586	1,554	1,681	1,786	1,621	1,520
Total non-current financial liabilities	2%	2,889	2,833	2,841	2,944	2,577	2,225
Total non-current liabilities	2.1%	3,263	3,197	3,216	3,324	2,949	2,612
Borrowings, current	-9.2%	209	230	205	170	175	240
Total current financial liabilities	10.1%	1,300	1,181	1,207	1,161	1,035	1,062
Provisions, current	9.4%	140	128	123	101	123	77
Total current liabilities	10.3%	1,589	1,441	1,444	1,370	1,257	1,243
Total liabilities	4.6%	4,852	4,638	4,659	4,694	4,206	3,856
Equity share capital	0%	72	72	72	72	72	72
Total equity	6.7%	9,315	8,734	8,190	7,711	7,294	6,925
Total equity and liabilities	5.9%	14,167	13,372	12,850	12,405	11,500	10,780

Description	(%) Q/Q	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020
Finance costs	2%	458	449	381	379	-	-
Change in inventories	68.7%	-21	-69.2	42	-175.76	-	-
Depreciation	10.3%	758	687	615	601	-	-
Impairment loss / reversal	-	2	0	0	1.78	-	-
Unrealised forex losses/gains	0%	0.1	0.1	-0.29	-0.55	-	-
Dividend income	-	0.7	0	0	0	-	-
Adjustments for interest income	116.7%	92	43	44	35	-	-
Share-based payments	28.7%	113	88	76	2.56	-	-
Net Cashflows from Operations	10.2%	2,630	2,387	1,759	1,820	-	-
Income taxes paid (refund)	5.8%	494	467	382	204	-	-
Net Cashflows From Operating Activities	11.3%	2,136	1,920	1,377	1,616	-	-
Cashflows used in obtaining control of subsidiaries	-137%	0	3.7	50	100	-	-
Proceeds from sales of PPE	1455.6%	15	1.9	4.07	0	-	-
Purchase of property, plant and equipment	50.7%	1,713	1,137	1,129	657	-	-
Proceeds from sales of investment property	-	0	0	0	5.4	-	-
Proceeds from sales of long-term assets	-100.1%	0	817	0	0	-	-
Purchase of other long-term assets	-100.1%	0	1,171	0	0	-	-
Cash receipts from repayment of advances and loans made to other parties	-50.7%	8.4	16	2.98	11	-	-
Dividends received	-	9.8	0	5.04	0	-	-
Interest received	118.4%	84	39	44	36	-	-
Other inflows (outflows) of cash	-308.3%	-353.8	-85.9	49	-153.66	-	-
Net Cashflows From Investing Activities	-119.9%	-3,380.6	-1,537.1	-856.85	-790.73	-	-
Proceeds from changes in ownership interests in subsidiaries	-	0	0	4.54	0	-	-
Payments from changes in ownership interests in subsidiaries	-89.2%	2.4	14	0	1	-	-
Proceeds from issuing shares	3114.3%	46	2.4	0	0	-	-
Proceeds from borrowings	261.2%	2,551	707	585	426	-	-
Repayments of borrowings	74.3%	442	254	516	712	-	-
Payments of lease liabilities	-	256	0	197	60	-	-
Dividends paid	25.9%	278	221	258	43	-	-
Interest paid	-0.3%	302	303	251	376	-	-
Other inflows (outflows) of cash	-	1	0	0	0	-	-
Net Cashflows from Financing Activities	521.5%	1,317	-311.2	-633.33	-767.7	-	-
Net change in cash and cash eq.	1.4%	73	72	-113.13	57	-	-

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

APOLLOHOSP

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

APOLLOHOSP

APOLLOHOSP - Apollo Hospitals Enterprises Ltd. Share Price

APOLLOHOSP

Valuation

Fundamentals

Profitability

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

APOLLOHOSP

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Apollo Hospitals Enterprises Ltd. do?

Important Disclosure & Data Context

Valuation

Fundamentals

Profitability

Growth & Returns

Cash Flow & Liquidity

Balance Sheet

Capital Structure & Leverage

Dividend & Shareholder Returns

Investor Care

Financial Health

Technical Indicators

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

What does Apollo Hospitals Enterprises Ltd. do?

Important Disclosure & Data Context